LAURA WHITE: Open Payments
NPI 1700047511 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 69 payments from 18 companies in 2025. Trend: 2023 $2,564 · 2024 $1,681 · 2025 $1,476
Food & beverage: $1,387Education: $90
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 12 | $268 |
| ABBVIE INC. | 8 | $209 |
| Novartis Pharmaceuticals Corporation | 9 | $208 |
| GENZYME CORPORATION | 14 | $191 |
| Regeneron Healthcare Solutions, Inc. | 8 | $161 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
| Blueprint Medicines Corporation | 1 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| Amgen Inc. | 2 | $32 |
Products named: DUPIXENT, SKYRIZI, Sotyktu, NEMLUVIO, AYVAKIT, COSENTYX, Rhapsido, BOTOX.
Industry payments across TX — which companies pay providers there.
